Cancer Immunotherapy Market Is Expected to Reach US $124.88 Bn by 2024 – Pipeline and Player Performance …Digital JournalAlbany, NY — (SBWIRE) — 10/31/2017 — The growing incidences of cancer and a need to treat them is the key driver of the global… Continue reading
Xconomy |
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 … Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release) |
Xconomy |
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 … Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release) |
Xconomy |
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s
Xconomy A key study for Voyager Therapeutics and its experimental gene therapy for Parkinson’s disease will have to move ahead without help from pharmaceutical giant Sanofi, which has walked away from the deal. Global rights to Parkinson’s treatment VY-AADC01 … Sanofi walks away from Voyager’s phase 2/3 Parkinson’s gene therapyBSA bureau (press release) |
Alabama’s News Leader |
Chelsea clinic introduces oral immunotherapy for nut allergies
Alabama’s News Leader Last year, Laura started oral immunotherapy treatment to help desensitize her allergy to tree nuts. “This offers the therapy that allows them to get the food back in the diet safely, as long as it’s continued,” said Dr. Carolyn Comer, Medical Director … |
|
Dr. Frédéric Triebel Presented at the World Immunotherapy Congress 2017
Nasdaq SYDNEY, Australia, Oct. 31, 2017 (GLOBE NEWSWIRE) — Prima BioMed Ltd (ASX:PRR) (NASDAQ:PBMD) (“Prima”) announces that Dr. Frédéric Triebel, Prima’s Chief Scientific Officer and Medical Officer, gave an oral presentation at the World … |
|
Revolutionary Stem Cell Therapy for Knees, Also Known as Living ‘bandage’
Markets Insider Now, a new form of living ‘bandage’ using stem cell therapy is being trialed in humans, using technology developed by scientists in the Universities of Bristol and Liverpool in the UK. An initial form of the bandage has already been tested in five … |
|
Revolutionary Stem Cell Therapy for Knees, Also Known as Living ‘bandage’
Markets Insider Now, a new form of living ‘bandage’ using stem cell therapy is being trialed in humans, using technology developed by scientists in the Universities of Bristol and Liverpool in the UK. An initial form of the bandage has already been tested in five … |